Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bioseek Signs Drug Discovery Collaboration With Ono
Under the three-year research plan, BioSeek will apply its BioMAP platform in an exclusive collaboration centered on a specific drug target class designated by Ono, performing phenotypic screening
Under the three-year research plan, BioSeek will apply its BioMAP platform in an exclusive collaboration centered on a specific drug target class designated by Ono, performing phenotypic screening
The collaboration calls for Cornerstone to apply its Emulsiphan cancer selective delivery nanotechnology platform to a class of agents developed at the NCI’s Center for Cancer Research Nanobiology
Boehringer said that the study findings have demonstrated that the patients with advanced PD who were treated with Mirapex ER experienced superior symptom relief versus placebo. In addition,
Invisicare is the core technology in Skinvisible’s portfolio of products. Skinvisible licenses it products on an exclusive basis to companies seeking new products in the areas such as
Cambrex said that after the transaction, the business will be renamed Cambrex IEP and will remain in Wiesbaden, Germany. Steven Klosk, president and CEO of Cambrex, said: “In
Clinical evidence demonstrated that one day of unprotected sun exposure can lead to irreversible cell damage, which is associated with both morphological and histological changes. These changes can
Roche said that the CHMP positive opinion clears the way for EU approval and means that this group of patients may soon be able to benefit from earlier
Sotax is a Swiss-based provider of high-quality dissolution testing systems, composite assay and content uniformity workstations along with physical tablet testing instruments for the pharmaceutical industry. Pall said
Reportedly, in a separate transaction, Valeant is expected to acquire a new 165,000 square foot manufacturing plant approved to produce solids, semi-solids and liquids for approximately US$28m. Valeant
Kelly Services has entered into a $750m five-year contract with the National Institutes of Health (NIH), an agency of the US Department of Health and Human Services. The